v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net sales $ 98,906 $ 113,787
Cost of sales:    
Cost of product (excluding amortization) 25,376 31,235
Amortization of patented formulations 2,187 1,742
Total cost of sales 27,563 32,977
Gross profit 71,343 80,810
Operating expenses:    
Selling, general, and administrative 40,437 34,924
Amortization of other intangible assets 11,289 10,323
Total operating expenses 51,726 45,247
Operating income 19,617 35,563
Interest expense (14,504) (13,918)
Interest income 6,203 3,375
Other (expense) income, net (947) 242
Income before provision for income taxes 10,369 25,262
Income tax provision 2,623 4,298
Net income $ 7,746 $ 20,964
Net income per share:    
Basic (in usd per share) $ 0.01 $ 0.03
Diluted (in usd per share) $ 0.01 $ 0.03
Weighted average common shares outstanding:    
Basic (in shares) 660,821,930 651,730,993
Diluted (in shares) 663,565,291 683,485,182
Other comprehensive loss:    
Unrealized loss on derivatives, net of income tax effect $ (361) $ (557)
Total other comprehensive loss (361) (557)
Comprehensive income $ 7,385 $ 20,407

Source